Elevance Health's stock tumbles as profit dented by ‘unprecedented' Medicaid challenges
“We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic operating environment and unprecedented challenges in the Medicaid business,” Chief Executive Gail K. Boudreaux said in prepared remarks.
Elevance Health cuts annual profit forecast on persistently higher medical costs
Elevance Health cut its full-year profit forecast on Thursday, as it expects to pay out more in claims due to robust demand for medical care from members in its government-backed plans, sending its shares down 6% in premarket trading.
Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report?
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Elevance's Pre-Q3 Earnings Analysis: Smart Buy Now or Caution Ahead?
ELV's third-quarter results are likely to reflect growing operating income from the Carelon business.
Gear Up for Elevance Health (ELV) Q3 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Elevance is a high-quality compounder with consistent EPS growth, trading at a significant discount to peers like UnitedHealth, presenting an attractive entry point. Despite recent stock dips due to minor issues, Elevance's solid management, investment-grade balance sheet, and demographic tailwinds make it a lower-risk investment. Medicaid and Medicare Advantage concerns are manageable, with potential EPS impacts already factored into the current stock price.
Elevance Health (ELV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add Elevance Health Stock to Your Portfolio
ELV benefits from an increase in employer group fee-based memberships, partially offsetting the impact of Medicaid memberships.
Elevance Health Stock Has More to Offer: Should You Hold on Tight?
In the commercial category, an increase in individual as well as employer group fee-based memberships will continue supporting ELV's medical membership numbers.
Why Is Elevance Health (ELV) Up 7.3% Since Last Earnings Report?
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
Elevance Health: Healthcare Services Segment Is Gaining Traction
Elevance Health's health insurance segment is well diversified, with a meaningful exposure to commercial services-only memberships and Medicaid. ELV has been doing a great job handling the current environment of rising medical costs. The Healthcare Services segment is starting to meaningfully grow external revenue.
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. ELV reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion.
